Colorectal Cancer Clinical Trial
— CEOfficial title:
Usefulness of Chromoendoscopy for the Early Detection of Colorectal Cancer Associated With Inflammatory Bowel Disease
Verified date | September 2015 |
Source | Hospital Clinic of Barcelona |
Contact | n/a |
Is FDA regulated | No |
Health authority | Spain: Ethics Committee |
Study type | Observational [Patient Registry] |
To assess the feasibility and effectiveness of a program in L-IBD patients using CE targeted biopsies
Status | Completed |
Enrollment | 350 |
Est. completion date | May 2015 |
Est. primary completion date | June 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diagnosis of UC or colitis EC corroborated by clinical and histology - involvement of at least one third of the colon in patients with CD - involvement proximal to the rectum in patients with UC - Duration of disease > 10 years - No clinical activity: - May Score <6 - CDEIS <3.5 Exclusion Criteria: - Personal history of CRC - colectomy - coagulopathy - refusal to participate in the study - known allergy to indigo carmine - colonoscopy in the last 6 months |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Spain | Gastroenteroly Department, Hospital Clinic | Barcelona | |
Spain | Hospital de Sant Pau | Barcelona | |
Spain | Hospital del Mar | Barcelona | |
Spain | Hospital Sant Jaume de Calella | Calella | Barcelona |
Spain | Hospital Universitario de Bellvitge | Hospitalet de Llobregat | Barcelona |
Spain | Hospital 12 de Octubre | Madrid | |
Spain | Hospital Puerta del Hierro | Madrid | |
Spain | Hospital Ramón y Cajal | Madrid | |
Spain | Hospital General de Manresa | Manresa | Barcelona |
Spain | Hospital general de Mostoles | Mostoles | Madrid |
Spain | Complexo Hospitalario Universitario de Ourense | Ourense | Pontevedra |
Spain | Hospital Universitario de Canarias | Tenerife | |
Spain | Hospital de la Fe | Valencia | |
Spain | Hospital Peset | Valencia | |
Spain | Complexo Hospitalario Universitario de Vigo | Vigo | Pontevedra |
Lead Sponsor | Collaborator |
---|---|
Hospital Clinic of Barcelona | Complexo Hospitalario de Ourense, Complexo Hospitalario Universitario de Vigo, Hospital de Calella, Hospital de Manresa, Hospital de Sant Pau, Hospital del Mar, Hospital General de Mostoles, Hospital Universitari de Bellvitge, Hospital Universitario 12 de Octubre, Hospital Universitario de Canarias, Hospital Universitario Doctor Peset, Hospital Universitario La Fe, Hospital Universitario Ramon y Cajal, Puerta de Hierro University Hospital |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Prevalence and incidence of dysplasia and colitis-associated colorectal cancer in patients with longstanding colonic inflammatory bowel disease (N-IBD), in Spain | see title | two year | No |
Secondary | Usefulness of advanced endoscopy in displasia characterization (chromoendoscopy ) for the diagnosis and endoscopic differential diagnosis of NIBD. | see title | two year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |